Global Chronic Inflammatory Demyelinating Polyneuropathy Market Share and Growth by Regional Analysis 2020
Market Research Future stated that The Global Chronic Inflammatory Demyelinating Polyneuropathy Market is set to the cross the mark of USD 3907.17 million during the forecast period, 2015-2023. The prevalence of autoimmune diseases has increased dramatically, paving the way for the growth of the global market for chronic inflammatory demyelinating polyneuropathy (CIDP). The increasing incidence of CIDP is a major concern in the medical sector, especially in developed countries. Several public and private organizations launched initiatives for R&D activities that produced positive results in the area of CIDP. Remarkable results have been achieved through rigorous research and development efforts and clinical trials. Several new drugs are introduced following recent FDA approvals, which also spur growth of the global chronic inflammatory demyelinating polyneuropathy market. Other factors supporting the market growth comprise growing awareness of the disease and gover...